UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

T2w‐MRI signal normalization affects radiomics features reproducibility

Medical physics (Lancaster), 2020-04, Vol.47 (4), p.1680-1691

2020

Volltextzugriff (PDF)

A Deletion of the Nuclear Localization Signal Domain in the Fus Protein Induces Stable Post-stress Cytoplasmic Inclusions in SH-SY5Y Cells

Frontiers in neuroscience, 2021-12, Vol.15, p.759659-759659

2021

Volltextzugriff (PDF)

Phase II Study of Imatinib in Advanced Chordoma

Journal of clinical oncology, 2012-03, Vol.30 (9), p.914-920

2012

Volltextzugriff (PDF)

Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis

The cancer journal (Sudbury, Mass.), 2017-03, Vol.23 (2), p.86-91

2017

Volltextzugriff (PDF)

Imatinib in advanced chordoma: A retrospective case series analysis

European journal of cancer (1990), 2015-11, Vol.51 (17), p.2609-2614

2015

Volltextzugriff (PDF)

High-grade soft-tissue sarcomas: tumor response assessment--pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria

Radiology, 2009-05, Vol.251 (2), p.447-456

2009

Volltextzugriff (PDF)

Sunitinib malate and figitumumab in solitary fibrous tumor: patterns and molecular bases of tumor response

Molecular cancer therapeutics, 2010-05, Vol.9 (5), p.1286-1297

2010

Volltextzugriff (PDF)

CEC enantioseparations on chiral monolithic columns: A study of the stereoselective degradation of (R/S)-dichlorprop [2-(2,4-dichlorophenoxy)propionic acid] in soil

Electrophoresis, 2007-08, Vol.28 (15), p.2613-2618

2007

Volltextzugriff (PDF)

Serological identification of HSP105 as a novel non-Hodgkin lymphoma therapeutic target

Blood, 2011-10, Vol.118 (16), p.4421-4430

2011

Volltextzugriff (PDF)

Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study

Journal of clinical oncology, 2018-12, Vol.36 (34), p.3353-3360

2018

Volltextzugriff (PDF)

Re: Valeria Panebianco, Yoshifumi Narumi, Ersan Altun, et al. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol 2018;74:294–306: Validating VI-RADS Criteria Within Immune-oncology Strategies (VI-RADS-IO)

European urology, 2018-11, Vol.74 (5), p.e107-e108

2018

Volltextzugriff (PDF)

Re: Valeria Panebianco, Yoshifumi Narumi, Ersan Altun, et al. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol 2018;74:294–306

European urology, 2018-11, Vol.74 (5), p.e107-e108

2018

Volltextzugriff (PDF)

Inhibition of Polyphenol Oxidases Activity by Various Dipeptides

Journal of agricultural and food chemistry, 2004-05, Vol.52 (10), p.2741-2745

2004

Volltextzugriff (PDF)

Radiomic analysis of soft tissues sarcomas can distinguish intermediate from high‐grade lesions

Journal of magnetic resonance imaging, 2018-03, Vol.47 (3), p.829-840

2018

Volltextzugriff (PDF)

Neoadjuvant chemotherapy in high‐risk soft tissue sarcomas: A Sarculator‐based risk stratification analysis of the ISG‐STS 1001 randomized trial

Cancer, 2022-01, Vol.128 (1), p.85-93

2022

Volltextzugriff (PDF)

Enantioseparation of 2-aryloxypropionic acids on chiral porous monolithic columns by capillary electrochromatography

Journal of Chromatography A, 2006-07, Vol.1120 (1), p.69-74

2006

Volltextzugriff (PDF)

Cáncer de próstata, el problema del diagnóstico ¿Es la resonancia multiparamétrica de próstata la solución?

Revista chilena de radiología, 2019-06, Vol.25 (2), p.60-66

2019

Volltextzugriff (PDF)

Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GIST

Annals of surgery, 2007-03, Vol.245 (3), p.341-346

2007

Volltextzugriff (PDF)

Imatinib and everolimus in patients with progressing advanced chordoma: A phase 2 clinical study

Cancer, 2018-10, Vol.124 (20), p.4056-4063

2018

Volltextzugriff (PDF)

Assessment of Stability and Discrimination Capacity of Radiomic Features on Apparent Diffusion Coefficient Images

Journal of digital imaging, 2018-12, Vol.31 (6), p.879-894

2018

Volltextzugriff (PDF)

MP56-02 NEOADJUVANT PEMBROLIZUMAB MAY RESULT IN LONG-TERM OUTCOME IMPROVEMENT IN BIOMARKER-UNSELECTED PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER (MIBC): UPDATED RESULTS FROM PURE-01

The Journal of urology, 2022-05, Vol.207 (Supplement 5)

2022

Volltextzugriff (PDF)

Texture analysis of T1‐w and T2‐w MR images allows a quantitative evaluation of radiation‐induced changes of internal obturator muscles after radiotherapy for prostate cancer

Medical physics (Lancaster), 2018-04, Vol.45 (4), p.1518-1528

2018

Volltextzugriff (PDF)

PECULIAR: An open label, multicenter, single-arm, phase 2 study of neoadjuvant pembrolizumab (PEM) and epacadostat (EPA), preceding radical cystectomy (Cy), for patients (pts) with muscle-invasive urothelial bladder cancer (MIUBC)

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.TPS534-TPS534

2018

Volltextzugriff (PDF)

1 – 25 von 417

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(375)
Mit Volltextzugriff
(352)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

T2w‐MRI signal normalization affects radiomics features reproducibility

A Deletion of the Nuclear Localization Signal Domain in the Fus Protein Induces Stable Post-stress Cytoplasmic Inclusions in SH-SY5Y Cells

Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study

Phase II Study of Imatinib in Advanced Chordoma

Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis

Imatinib in advanced chordoma: A retrospective case series analysis

High-grade soft-tissue sarcomas: tumor response assessment--pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria

Sunitinib malate and figitumumab in solitary fibrous tumor: patterns and molecular bases of tumor response

CEC enantioseparations on chiral monolithic columns: A study of the stereoselective degradation of (R/S)-dichlorprop [2-(2,4-dichlorophenoxy)propionic acid] in soil

Serological identification of HSP105 as a novel non-Hodgkin lymphoma therapeutic target

Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study

Re: Valeria Panebianco, Yoshifumi Narumi, Ersan Altun, et al. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol 2018;74:294–306: Validating VI-RADS Criteria Within Immune-oncology Strategies (VI-RADS-IO)

Re: Valeria Panebianco, Yoshifumi Narumi, Ersan Altun, et al. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol 2018;74:294–306

Inhibition of Polyphenol Oxidases Activity by Various Dipeptides

Radiomic analysis of soft tissues sarcomas can distinguish intermediate from high‐grade lesions

Neoadjuvant chemotherapy in high‐risk soft tissue sarcomas: A Sarculator‐based risk stratification analysis of the ISG‐STS 1001 randomized trial

Enantioseparation of 2-aryloxypropionic acids on chiral porous monolithic columns by capillary electrochromatography

Cáncer de próstata, el problema del diagnóstico ¿Es la resonancia multiparamétrica de próstata la solución?

Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GIST

LBA03-12 BIOLOGY AND PERFORMANCE OF PRE- AND POST-PEMBROLIZUMAB (PEMBRO) VESICAL IMAGING-REPORTING AND DATA SYSTEM (VI-RADS) TO PREDICT THE PATHOLOGICAL RESPONSE IN MUSCLE-INVASIVE UROTHELIAL BLADDER CANCER (MIBC): FULL DATA ANALYSIS FROM A CLINICAL TRIALS PIPELINE

Imatinib and everolimus in patients with progressing advanced chordoma: A phase 2 clinical study

Assessment of Stability and Discrimination Capacity of Radiomic Features on Apparent Diffusion Coefficient Images

MP56-02 NEOADJUVANT PEMBROLIZUMAB MAY RESULT IN LONG-TERM OUTCOME IMPROVEMENT IN BIOMARKER-UNSELECTED PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER (MIBC): UPDATED RESULTS FROM PURE-01

Texture analysis of T1‐w and T2‐w MR images allows a quantitative evaluation of radiation‐induced changes of internal obturator muscles after radiotherapy for prostate cancer

PECULIAR: An open label, multicenter, single-arm, phase 2 study of neoadjuvant pembrolizumab (PEM) and epacadostat (EPA), preceding radical cystectomy (Cy), for patients (pts) with muscle-invasive urothelial bladder cancer (MIUBC)

Suchergebnisse filtern